projects
below are select manuscripts and abstracts of projects that our team has conducted.
current_projects
protocols
Medication use, health care resource utilization, and cost of adults living with MS in Alberta.
Version 1
October, 2022
view manuscript
Care patterns among adults with newly diagnosed multiple sclerosis in Alberta.
Version 1
October, 2022
view manuscript
The incremental health care cost of migraine in Alberta.
Version 1
August, 2022
view manuscript
Post-stroke care pathways and spasticity treatment in Alberta.
Version 1
January, 2022
view manuscript
completed_projects
select manuscripts
Post-stroke care pathways and spasticity treatment: A retrospective study in Alberta.
Satkunam, L, Dukelow, S, Yu, J, McNeil, S, Luu, H, Martins, K, Vu, H, Nguyen, PU, Richer, L, Williamson, T, Klarenbach, S. Canadian Journal of Neurological Sciences. 2024;1-10. doi: 10.1017/cjn.2024.42.
Disease-modifying therapy use and health resource utilisation associated with multiple sclerosis over time: A retrospective cohort study from Alberta, Canada.
Balcom, E, Smyth, P, Kate, M, Vu, K, Martins, K, Aponte-Hao, S, Luu, H, Richer, L, Williamson, T, Klarenbach, S, McCombe, J. Journal of the Neurological Sciences. 2024;Mar 15:458. doi: 10.1016/j.jns.2024.122913.
Geographical variation in medication and health resource use in multiple sclerosis.
Balcom, E, McCombe, J, Kate, M, Vu, K, Martins, K, Aponte-Hao, S, Luu, H, Richer, L, Williamson, T, Klarenbach, S, Smyth, P. Canadian Journal of Neurological Sciences. 2024;April 11:1-9. doi: 10.1017/cjn.2024.54.
Health care cost of severe obesity and obesity-related comorbidities: A retrospective cohort study from Alberta, Canada.
Butalia, S, Luu, H, Guigue, A, Martins, K, Williamson, T, Klarenbach, S. Obesity Research & Clinical Practice. 2023;Sep 12:S1871-403X(23)00109-6. doi: 10.1016/j.orcp.2023.09.006.
Analgesic use among adults with a trauma-related emergency department visit: A retrospective cohort study from Alberta, Canada.
Sevcik, B, Lobay, K, Luu, H, Martins, K, Vu, K, Nguyen, PU, Bohlouli, S, Eurich, D, Lester, E, Williamson, T, Richer, L, Klarenbach, S. Pain and Therapy. 2023;12(4):1039-1053. doi: 10.1007/s40122-023-00521-1.
Incidence and prevalence, and medication use among adults living with dermatomyositis: An Alberta, Canada population-based cohort study.
Osman, M, Martins, K, Wong, KO, Vu, K, Guigue, A, Cohen Tervaert, J, Gniadecki, R, Klarenbach, S. Scientific Reports. 2023; 13(1):16444. doi: 10.1038/s41598-023-43880-7.
select abstracts
Healthcare resource utilisation and disease-modifying therapy use over time among adults with newly diagnosed multiple sclerosis: a retrospective cohort study from Alberta.
Balcom, E, Smyth, P, McCombe, J, Kate, M, Vu, K, Martins, K, Aponte-Hao, S, Richer, L, and Klarenbach, S. The endMS Conference. 2023 Dec, Toronto, ON.
Population based analysis of outcomes among persons with type 2 diabetes and chronic kidney disease.
Klarenbach, S, Collister, D, Bello, A, Wiebe, N, So, H, and Pannu, N. Canadian Society of Nephrology. 2022 May Montreal, PQ.
Comparing Cortiment™ and prednisone in ulcerative colitis: a population-based study of outcomes.
Coward, S, Martins, K, Klarenbach, S, Kroeker, K, Ma, C, Panaccione, R, Richer, L, Seow, C, Targownik, L, and Kaplan, G. Journal of the Canadian Association of Gastroenterology. 2022 Mar; 5(Suppl 1):33-35. doi: 10.1093/jcag/gwab049.157.
Health care resource utilization among patients with depression before and after initiating vortioxetine.
Chue, P, Martins, K, Wong, K, Ahmed, G, Klarenbach, S, and Richer, L. 34th ECNP Congress Hybrid, October 2021. CG21-0275.
Opioid use in medical cannabis authorization adult patients from 2013-2018: Alberta, Canada.
Cerina L, Mu L, Martins K, Dyck J, Klarenbach S, Richer L, Jess E, Hanlon J, Hyshka E, and Eurich D. Canadian Public Health Association Conference. 2021 Oct.
Real-world use of Cortiment™ in ulcerative colitis: A population-based study.
Coward, S, Martins, K, Klarenbach, S, Kroeker, K, Ma, C, Panaccione, R, Richer, L, Seow, C, Targownik, L, and Kaplan, G. Journal of the Canadian Association of Gastroenterology. 2021 Mar; 4(Suppl 1):161-162. doi: 10.1093/jcag/gwab002.153.
